Document is current
Any future updates will be listed below
-
Authors
Burgess, Philip I. https://orcid.org/0000-0002-3959-2299
Dinah, Christiana https://orcid.org/0000-0002-0815-4771
Lois, Noemi https://orcid.org/0000-0003-2666-2937
Burdon, Michael
- License Information
-
More Information
Article History
Received: 19 June 2025
Revised: 6 October 2025
Accepted: 7 November 2025
First Online: 4 December 2025
Competing interests
: Dr Burgess has received compensation for consulting and speaker fees from Roche, Bayer and Alimera Sciences. Dr. Dinah has received compensation for consulting and speaker fees from Bayer, Boehringer Ingelheim, Roche, Eyepoint, Abbvie and Alimera Sciences and an institutional research grant from Roche. Professor Lois and Mr Burdon declare no potential competing interests.
Free to read: This content has been made available to all.
